Demand Soars For Newly Approved Use of Botox To Remove Crow's Feet
Recent FDA Approval Spurs Pent-Up Demand Among the Middle Aged
Online, September 20, 2013 (Newswire.com) - The FDA's recent approval of using Botox to eliminate crow's feet is triggering high demand among middle-agers who have had little success removing the lines and creases commonly found in the corner of their eyes. The new technique involves injecting Botox in those areas to smooth out the wrinkles.
According to board-certified plastic surgeon Michael Nicole M.D., medical director and founder of CosmetiCare in Newport Beach, his office averages 20 calls each day since the FDA made their announcement last week.
"Up until now there have been few procedures that have been able to effectively eliminate those pesky fine lines and wrinkles around the eyes. While this is a great innovation, those contemplating this treatment should opt for an expert with experience using Botox. When too much is administered, the patient can walk away with 'droopy eyes,' a phenomenon whereby the lids begin to sag resulting in an unpleasant appearance and potential disruption in function. While it's not permanent, it's an undesirable side effect that patients needn't go through. "
For more information or a free consultation to see if you're a candidate for this procedure call (949) 718-6900 or visit www.cosmeticare.com.
CosmetiCare is one of the most noted plastic surgery centers in the nation and has been helping women and men alike achieve a youthful natural appearance for more nearly 3 decades through a combination of state-of-the-art surgical procedures and the latest advances in nonsurgical techniques. A portion of the revenue generated at CosmetiCare is donated to the Magic Mirror Foundation, a nonprofit that has brought no-cost plastic surgery services to those in need including domestic abuse and accident victims and children from third world countries living with abnormalities. CosmetiCare is located at 1101 Bayside Drive, Newport Beach.
Share:
Tags: Botox, crows feet, FDA.